Table 4.
Median ± (IQRs) | P value | F value | P value | |||||
---|---|---|---|---|---|---|---|---|
t0 | t1 | t2 | t0 vs t1 | t0 vs t2 | t1 vs t2 | |||
ADMN | 1.2 (0.7–1.8) | 1.8 (1.4–1.8) | 1.2 (0.8–1.7) | 0.015 | 0.658 | 0.005 | 5.110 | 0.010 |
PDMN | 0.8 (0.5–1.2) | 1.2 (1.0–1.5) | 1.0 (0.7–1.3) | 0.001 | 0.270 | 0.012 | 7.321 | 0.002 |
LFPN | 1.3 (1.2–2.0) | 2.0 (1.6–2.3) | 1.5 (1.1–1.9) | 0.037 | 0.464 | 0.006 | 4.469 | 0.017 |
RFPN | 2.0 (1.4–2.4) | 2.5 (2.0–3.2) | 2.0 (1.7–2.5) | 0.006 | 0.489 | 0.034 | 4.518 | 0.016 |
CN | 2.4 (1.4–2.9) | 3.7 (2.5–4.9) | 2.3 (1.7–2.9) | 0.000 | 0.812 | 0.001 | 12.163 | 0.001 |
SRN | 1.2 (0.9–1.7) | 2.0 (1.2–2.2) | 1.1 (0.7–1.7) | 0.011 | 0.722 | 0.004 | 5.381 | 0.008 |
VN | 2.1 (1.7–2.8) | 1.5 (1.1–2.1) | 2.2 (1.8–3.5) | 0.123 | 0.087 | 0.002 | 5.503 | 0.007 |
t0, baseline assessment; t1, one week after chemotherapy; t2, six months after chemotherapy